Architha Reddy on Integrating rTMS with Speech-Language Therapy in Post-Stroke Aphasia
Architha Reddy, Speech Language Pathologist at Talking Tales Speech therapy Clinic, shared on LinkedIn:
”Integrating rTMS with Speech-Language Therapy in Post-Stroke Aphasia
Repetitive Transcranial Magnetic Stimulation (rTMS), when combined with Speech-Language Therapy (SLT), is emerging as an effective adjunct in the rehabilitation of post-stroke aphasia.
This non-invasive neuromodulation technique targets cortical language networks to facilitate neuroplasticity and optimize therapy outcomes.
Clinical Rationale
•Inhibitory low-frequency rTMS to right-hemisphere language homologues reduces maladaptive interhemispheric inhibition
•Excitatory rTMS over perilesional left-hemisphere regions supports language network reactivation
Therapy-Driven Outcomes
When paired with structured, task-specific SLT, patients demonstrate measurable gains in:
•Naming and word retrieval
•Auditory comprehension
•Repetition
•Spontaneous verbal output
Evidence Highlights
•Right pSTG ( posterior superior temporal gyrus) inhibition improves comprehension and repetition
•Combined rTMS + intensive SLT enhances perilesional activation and microstructural integrity
•Subacute patients show faster and more robust naming recovery than chronic cases
Clinical Takeaway
When applied using evidence-based protocols, rTMS enhances neuroplastic responsiveness to speech-language therapy, leading to more targeted and functionally meaningful language gains, including measurable improvements in Aphasia Quotient (AQ) scores on the WAB in both subacute and chronic post-stroke aphasia.”
Stay updated with Hemostasis Today.
-
Apr 1, 2026, 18:46Fritz Torto: Why Every Survivor Has a Duty to Build a Stronger Future for Others
-
Apr 1, 2026, 17:47Akshaya Sharon: Qfitlia as a Shift in Treatment Strategy for Hemophilia A and B
-
Apr 1, 2026, 17:21Antonio Pineda Guerrero: Elevated Lp(a) Raises VTE Risk But Only in the Right Hormonal Context
-
Apr 1, 2026, 17:19Shaik Nayeem Uddin: Clopidogrel and Omeprazole Combination Can Quietly Reduce A Life-Saving Effect
-
Apr 1, 2026, 17:18John Abraham: Breaking the ‘Bleeding Disorder’ Myth About Cirrhosis and Coagulation
-
Apr 1, 2026, 17:17Heghine Khachatryan: Linking Coagulation, Inflammation, and Neurodegeneration In Neuro-Hemostasis Axis
-
Apr 1, 2026, 17:15Chokri Ben Lamine: Differentiating Reactive from Clonal Causes in Adult Neutrophilia
-
Apr 1, 2026, 16:05Gregory Piazza: Discussing the 2026 AHA/ACC Guidelines for Acute PE at ACC.26
-
Apr 1, 2026, 15:31Simon Senanu: A Stepwise Laboratory Approach for aPTT Prolongation